Pishvaian MJ, Lee MS, Ryoo B, et al. Updated safety and clinical activity results from a Phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC). ESMO 2018, abstract LBA26.
Adagrasib met of zonder cetuximab bij KRASG12C-gemuteerd colorectaal carcinoom
mrt 2023 | Maag-darm-leveroncologie